Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative
delivery platform, DehydraTECH™, has demonstrated excellent results in delivery
of nicotine to the brain in a recent lab study. An article discussing this
reads, “The new report confirmed first generation results of in vivo tests on
live animals showing that DehydraTECH™ was able to deliver more active
pharmaceutical ingredients (APIs) across the brain’s protective blood brain
barrier, as reported in an article published by the CFN Media Group (http://ibn.fm/rqa7h). Because of
certain similarities in physical structure between the nicotine molecule and
several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,
schizophrenia and depression, it is now theorized that DehydraTECH could offer
similar delivery advantages.”
To view the full article, visit http://ibn.fm/SzJoc
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment